VAERS reports by lot
Sanofi Pasteur DTaP/Tdap lot U7838AA: VAERS reports
26 VAERS reports list lot U7838AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2023-08-10 and 2025-08-18. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).
Symptom categories in these reports
A report can mention several categories, so the counts add up to more than the number of reports.
| Category | Count | % |
|---|---|---|
| Injection-site / Local reaction | 25 | 45% |
| Dermatological (non-injection-site) | 12 | 21% |
| Allergic / Anaphylactic | 9 | 16% |
| Neurological | 3 | 5% |
| Psychiatric / Neuropsychiatric | 3 | 5% |
| Musculoskeletal | 2 | 4% |
| General / Systemic (non-local) | 2 | 4% |
Where reports came from
U.S. state of the reporter, where given (top 12).
| State | Reports |
|---|---|
| Pennsylvania | 4 |
| Colorado | 3 |
| Virginia | 3 |
| Kentucky | 2 |
| Ohio | 2 |
| Michigan | 2 |
| Arizona | 2 |
| Oregon | 2 |
| Illinois | 1 |
| New Jersey | 1 |
| Florida | 1 |
| Texas | 1 |
Reports by month received
| Month | Reports | Bar |
|---|---|---|
| 2023-08 | 1 | |
| 2023-09 | 2 | |
| 2024-04 | 1 | |
| 2024-05 | 1 | |
| 2024-08 | 1 | |
| 2024-09 | 2 | |
| 2024-11 | 3 | |
| 2025-01 | 1 | |
| 2025-02 | 3 | |
| 2025-03 | 3 | |
| 2025-06 | 4 | |
| 2025-07 | 1 | |
| 2025-08 | 3 |
Products recorded with this lot
- DTAPIPV — Sanofi Pasteur (26 reports)
Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.
Related
- All Sanofi Pasteur DTaP/Tdap lots with VAERS reports
- DTaP/Tdap vaccine lot number lookup
- DTaP/Tdap vaccine side effects, trials and ingredients
- Daptacel: ingredients, package insert and side effects
- Look up a lot for any vaccine
Nearby Sanofi Pasteur DTaP/Tdap lots (A–Z): U7564AA · U7624AA · U7656AA · U7904AA · U7920AA · U7927AA
Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.